July 31, 2012 at 8:26 AM
Topics: Crystal Research Associates, Newsworthy Events, Unilife Corp., Prefilled Syringe
July 24, 2012 at 12:18 PM
Amid a depressed global economic environment, investments in cleantech were estimated to total $1.6 billion in the second quarter 2012, down from $1.9 billion in the first quarter 2012and $2.1 billion in the comparable year-ago period (second quarter 2011). Factors driving down investment include global economic uncertainties as well as political opposition to government subsidies in areas such as solar and wind power and electric vehicle development. A depressed U.S. IPO market is further hampering greentech funding efforts.
Topics: Crystal Research Associates, nanotechnology, built environment, green infrastructure, Newsworthy Events, Soladigm
July 16, 2012 at 4:27 PM
Novel biotech company AtheroNova Inc. (AHRO-OTC) made a significant news announcement last week when it reported the receipt of a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its main patent. The Notice of Allowance entailed written communication from the USPTO to AtheroNova that the Company’s primary patent was allowable. A Notice of Allowance specifies the amount of issue and/or publication fees that are due within three months in order to avoid abandonment of the applications (Source: USPTO). Accordingly, AtheroNova expects to announce the official patent issuance within the next few months once the registration process is complete.
Topics: AtheroNova, Crystal Research Associates, Newsworthy Events, New Research
We provide investor-based research and corporate communications services to companies worldwide. Visit our About Us page to learn more.